(Q45863017)

17 December 2017

title

Immunogene therapy using immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma (English)

1 reference

17 December 2017

author

Toshimitsu Hamasaki

4

1 reference

17 December 2017

Keisuke Nimura

2

object named as

Keisuke Nimura

1 reference

17 December 2017

author name string

Masahide Matsuda

1

1 reference

17 December 2017

Takashi Shimbo

3

1 reference

17 December 2017

Tetsuya Yamamoto

5

1 reference

17 December 2017

Akira Matsumura

6

1 reference

17 December 2017

Yasufumi Kaneda

7

1 reference

17 December 2017

publication date

22 August 2010

1 reference

17 December 2017

Journal of Neuro-Oncology

published in

1 reference

17 December 2017

volume

103

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

19-31

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1007/s11060-010-0355-x

exact match

0 references

cites work

Relative survival rates and patterns of diagnosis analyzed by time period for individuals with primary malignant brain tumor, 1973-1997.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Recent advances in the treatment of malignant astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Antigen presentation in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Three or more routes for leukocyte migration into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

A new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

New Vector Innovation for Drug Delivery: Development of Fusigenic Non- Viral Particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Development of HVJ envelope vector and its application to gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Targeted chemotherapy against intraperitoneally disseminated colon carcinoma using a cationized gelatin-conjugated HVJ envelope vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Controlling brain tumor growth by intraventricular administration of an AAV vector encoding IFN-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

How regulatory T cells work

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: biological and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Eradication of murine brain tumors by direct inoculation of concentrated high titer-recombinant retrovirus harboring the herpes simplex virus thymidine kinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Tolerance, not immunity, crucially depends on IL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Interleukin 2 signaling is required for CD4(+) regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Paracrine cytokine adjuvants in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Sendai virus F glycoprotein induces IL-6 production in dendritic cells in a fusion-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

Highly efficient eradication of intracranial glioblastoma using Eg5 siRNA combined with HVJ envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0355-X

The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation

21 January 2018

1 reference

12 December 2020

Granulocyte macrophage-colony stimulating factor gene transfer to induce a protective anti-tumoral immune response against the 9L rat gliosarcoma model.

1 reference

12 December 2020

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells

1 reference

12 December 2020

The Ommaya reservoir in chemotherapy for malignant disease in the CNS

1 reference

12 December 2020

Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye.

1 reference

12 December 2020

The role of regulatory T cells in malignant glioma.

1 reference

12 December 2020

Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo

1 reference

12 December 2020

Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma

1 reference

12 December 2020

Adenovirus mediated transfer of p53, GM-CSF and B7-1 suppresses growth and enhances immunogenicity of glioma cells

1 reference

12 December 2020

Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon

1 reference

12 December 2020

In vitro and in vivo bioactivity of single-chain interleukin-12

1 reference

12 December 2020

Suppression of malignant glioma recurrence in a newly developed animal model by endogenous inhibitors.

1 reference

12 December 2020

10.1007/S11060-010-0355-X

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017